Publications by authors named "Ronald Feld"

Claim this Profile
I
Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma.
Sabine Schmid, Luna Zhan, Miguel Garcia, Kristen Dietrich, Khaleeq Khan, Ronald Feld

Clin Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Ethnicity on Outcomes of Patients With Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection.
Mike R Sung, Pascale Tomasini, Lisa W Le, Suzanne Kamel-Reid, Ming-Sound Tsao, Ronald Feld

JTO Clin Res Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre.
Sabine Schmid, Luna Zhan, Kristen Dietrich, Khaleeq Khan, Maisha Chowdhury, Ronald Feld

Clin Lung Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective study of the incidence and outcomes from lung cancer in solid organ transplant recipients.
Kelvin Young, Haiyan Jiang, Max Marquez, Jonathan Yeung, Frances A Shepherd, Ronald Feld

Lung Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
Sara V Soldera, John Kavanagh, Melania Pintilie, Natasha B Leighl, Marc de Perrot, Ronald Feld

Oncologist· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer.
Alona Zer, Mike R Sung, Preet Walia, Leila Khoja, Manjula Maganti, Ronald Feld

Clin Lung Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Kevin Jao, Pascale Tomasini, Suzanne Kamel-Reid, Gregorz J Korpanty, Céline Mascaux, Ronald Feld

Lung Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer in never smokers from the Princess Margaret Cancer Centre.
Grzegorz J Korpanty, Suzanne Kamel-Reid, Melania Pintilie, David M Hwang, Alona Zer, Ronald Feld

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
Catherine Labbé, Michael Cabanero, Grzegorz J Korpanty, Pascale Tomasini, Mark K Doherty, Ronald Feld

Lung Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib chemotherapy in advanced non-small cell lung cancer patients.
Lucia Kim, Mauro Saieg, Massimo Di Maio, Ciro Gallo, Charles Butts, Ronald Feld

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon EGFR mutations in advanced non-small cell lung cancer.
Grainne M O'Kane, Penelope A Bradbury, Ronald Feld, Natasha B Leighl, Geoffrey Liu

Lung Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade.
Mike R Sung, Milan V Patel, Sarvar Djalalov, Lisa W Le, Frances A Shepherd, Ronald Feld

Clin Lung Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Mark K Doherty, Grzegorz J Korpanty, Pascale Tomasini, Moein Alizadeh, Kevin Jao, Ronald Feld

Radiother Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
Alona Zer, Mor Moskovitz, David M Hwang, Anat Hershko-Klement, Ludmila Fridel, Ronald Feld

Clin Lung Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma.
Marc de Perrot, Zhi Dong, Penelope Bradbury, Demetris Patsios, Shaf Keshavjee, Ronald Feld

Eur Respir J· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207.
Paul Wheatley-Price, Quincy Chu, Maria Bonomi, Jean Seely, Ashish Gupta, Ronald Feld

J Thorac Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
Pierre Mordant, Karen McRae, John Cho, Shaf Keshavjee, Thomas K Waddell, Ronald Feld

Eur J Cardiothorac Surg· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Anthony B Miller, Ronald Feld, Robert Fontana, John K Gohagan, Ismail Jatoi

Rev Recent Clin Trials· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.
Harvey I Pass, Chandra Goparaju, Osvaldo Espin-Garcia, Jessica Donington, Michele Carbone, Ronald Feld

J Thorac Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.
Anthony Brade, Robert MacRae, Scott A Laurie, Andrea Bezjak, Ronald Burkes, Ronald Feld

Clin Lung Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell

J Thorac Cardiovasc Surg· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
Charles Lim, Mike Sung, Frances A Shepherd, Nazanin Nouriany, Magdalena Sawczak, Ronald Feld

J Thorac Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy.
Tetsuzo Tagawa, Masaki Anraku, Yosuke Morodomi, Tomoyoshi Takenaka, Tatsuro Okamoto, Ronald Feld

J Thorac Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, Maria Carmela Piccirillo, Gennaro Daniele, Ronald Feld

J Clin Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Abul Kalam Azad, Xin Qiu, Kevin Boyd, Qin Kuang, Marjan Emami, Ronald Feld

Lung Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis